1. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study. Issue 2 (February 2020) Authors: Lonial, Sagar; Lee, Hans C; Badros, Ashraf; Trudel, Suzanne; Nooka, Ajay K; Chari, Ajai; Abdallah, Al-Ola; Callander, Natalie; Lendvai, Nikoletta; Sborov, Douglas; Suvannasankha, Attaya; Weisel, Katja; Karlin, Lionel; Libby, Edward; Arnulf, Bertrand; Facon, Thierry; Hulin, Cyrille; Kortüm, K Mart... Journal: Lancet oncology Issue: Volume 21:Issue 2(2020) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial. Issue 1 (January 2021) Authors: Usmani, Saad Z; Hoering, Antje; Ailawadhi, Sikander; Sexton, Rachael; Lipe, Brea; Hita, Sandi Fredette; Valent, Jason; Rosenzweig, Michael; Zonder, Jeffrey A; Dhodapkar, Madhav; Callander, Natalie; Zimmerman, Todd; Voorhees, Peter M; Durie, Brian; Rajkumar, S Vincent; Richardson, Paul G; Orlowski... Journal: Lancet Issue: Volume 8:Issue 1(2021) Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial. Issue 10 (October 2020) Authors: Kumar, Shaji K; Jacobus, Susanna J; Cohen, Adam D; Weiss, Matthias; Callander, Natalie; Singh, Avina K; Parker, Terri L; Menter, Alexander; Yang, Xuezhong; Parsons, Benjamin; Kumar, Pankaj; Kapoor, Prashant; Rosenberg, Aaron; Zonder, Jeffrey A; Faber, Edward; Lonial, Sagar; Anderson, Kenneth C; R... Journal: Lancet oncology Issue: Volume 21:Issue 10(2020) Page Start: 1317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial. Issue 10027 (9th April 2016) Authors: Lonial, Sagar; Weiss, Brendan M; Usmani, Saad Z; Singhal, Seema; Chari, Ajai; Bahlis, Nizar J; Belch, Andrew; Krishnan, Amrita; Vescio, Robert A; Mateos, Maria Victoria; Mazumder, Amitabha; Orlowski, Robert Z; Sutherland, Heather J; Bladé, Joan; Scott, Emma C; Oriol, Albert; Berdeja, Jesus; Ghari... Journal: Lancet Issue: Volume 387:Issue 10027(2016) Page Start: 1551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications. (September 2020) Authors: D'Angelo, Christopher R.; Hall, Aric; Woo, Kaitlin M.; Kim, KyungMann; Longo, Walter; Hematti, Peiman; Callander, Natalie; Kenkre, Vaishalee P.; Mattison, Ryan; Juckett, Mark Journal: Leukemia research Issue: Volume 96(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Implementation of a chemotherapy stewardship process. (4th July 2020) Authors: Hennes, Emily R; Reed, Michael; Mably, Mary; Jared, Jason; Bergsbaken, Jason J; Deming, Dustin; Callander, Natalie; O'Regan, Ruth Journal: American journal of health-system pharmacy Issue: Volume 77:Number 15(2020) Page Start: 1243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study. Issue 22 (27th July 2021) Authors: Lonial, Sagar; Lee, Hans C.; Badros, Ashraf; Trudel, Suzanne; Nooka, Ajay K.; Chari, Ajai; Abdallah, Al‐Ola; Callander, Natalie; Sborov, Douglas; Suvannasankha, Attaya; Weisel, Katja; Voorhees, Peter M.; Womersley, Lynsey; Baron, January; Piontek, Trisha; Lewis, Eric; Opalinska, Joanna; Gupta, Ir... Journal: Cancer Issue: Volume 127:Issue 22(2021) Page Start: 4198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Macrophages in multiple myeloma: emerging concepts and therapeutic implications. Issue 10 (October 2013) Authors: Asimakopoulos, Fotis; Kim, Jaehyup; Denu, Ryan A.; Hope, Chelsea; Jensen, Jeffrey L.; Ollar, Samuel J.; Hebron, Ellen; Flanagan, Claire; Callander, Natalie; Hematti, Peiman Journal: Leukemia & lymphoma Issue: Volume 54:Issue 10(2013:Oct.) Page Start: 2112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MAP3K8 kinase regulates myeloma growth by cell‐autonomous and non‐autonomous mechanisms involving myeloma‐associated monocytes/macrophages. (18th December 2012) Authors: Hebron, Ellen; Hope, Chelsea; Kim, Jaehyup; Jensen, Jeffrey L.; Flanagan, Claire; Bhatia, Neehar; Maroulakou, Ioanna; Mitsiades, Constantine; Miyamoto, Shigeki; Callander, Natalie; Hematti, Peiman; Asimakopoulos, Fotis Journal: British journal of haematology Issue: Volume 160:Number 6(2013:Mar.) Page Start: 779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma. (23rd October 2020) Authors: Dhakal, Binod; D'Souza, Anita; Callander, Natalie; Chhabra, Saurabh; Fraser, Raphael; Davila, Omar; Anderson, Kenneth; Assal, Amer; Badawy, Sherif M.; Berdeja, Jesus; Cerny, Jan; Comenzo, Raymond; Chakraborty, Rajshekhar; Peter Gale, Robert; Kamble, Rammurti; Kharfan‐Dabaja, Mohamed A.; Krem, Max... Journal: British journal of haematology Issue: Volume 191:Number 3(2020) Page Start: 442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗